What is AMERISAFE, Inc.'s earnings per share (EPS)?

AMERISAFE, Inc. (AMSF) reported diluted earnings per share of $2.47 for fiscal year 2025. This represents a -14.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

AMERISAFE, Inc. (AMSF) Financials

AMSF

Trailing 12 months to June 30, 2026

Revenue $335.6M +9.5% YoY

Net Income $46.9M -6.8% YoY

EPS (Diluted) $2.48 -5.7% YoY

Free Cash Flow $19.3M +143.8% YoY

Market Cap $452.5M as of Oct 10, 2026

Price / Sales 1.3x on $335.6M revenue, trailing 12 months to June 30, 2026

Price / Earnings 9.6x on $46.9M net income, trailing 12 months to June 30, 2026

Price / Book 1.8x on $250.0M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Jul 23, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Jul 23, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AMSF SEC filings page.

AMERISAFE, Inc. (AMSF) reported $335.6M in revenue over the twelve months to Jun 30, 2026, up 9.5% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI AMSF FY2025 2026-10-03

Revenue held up, but AMERISAFE’s latest results show weaker margins, poorer cash conversion, and distributions against a thinner capital base.

Cash conversion deteriorated faster than profitability: FY2025 net income was $47.1M while operating cash flow was only $11.1M, showing that reported profits converted into substantially less cash. Free-cash-flow margin also fell from 7.6% to 2.8%, so the cash weakness was not explained simply by the earnings decline.

Revenue reached $317.3M in FY2025, up from $309.0M, but that modest expansion did not produce stronger economics. Net margin narrowed from 17.9% to 14.9%, indicating that additional revenue was accompanied by lower profit retained per dollar.

Dividends paid exceeded net income in both FY2024 and FY2025, indicating distributions were not fully funded by reported profit in either year. By FY2025, equity was $251.6M and debt-to-equity was 3.5x, so those distributions operated against a thinner capital base.

Financial Health Signals

Financial Health Score 53/100

Scored as: Insurers peer group

Scored against insurers for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of AMERISAFE, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Loss Ratio

Loss Ratio measures the claims an insurer paid out against the premiums it earned, so a lower ratio leaves more of every premium dollar with the company. AMERISAFE, Inc. scores 61/100 on it among other insurers.

Premium Growth

AMERISAFE, Inc. reported revenue of $317.3M in fiscal year 2025, against $309.0M in fiscal year 2024. Premium Growth ranks insurers on the three-year path of the premiums they write rather than on total revenue, and AMERISAFE, Inc. scores 42/100 among other insurers.

Capital

AMERISAFE, Inc. funded 22.3% of its assets with shareholders' equity at the end of fiscal year 2025, holding $251.6M of equity against $1.1B of assets. Capital ranks insurers on that cushion, and AMERISAFE, Inc. scores 43/100 among other insurers.

Investment Yield

Not available for AMERISAFE, Inc., and counted as zero in the overall score.

Combined Ratio

Combined Ratio puts claims and running costs together against premiums earned, and a figure under 100% means the underwriting made money before any investment income was counted. AMERISAFE, Inc. scores 75/100 on it among other insurers.

Stability

AMERISAFE, Inc. reported net income of $47.1M in fiscal year 2025, against $55.4M in fiscal year 2024. Stability ranks insurers on how steady net income has been across five years, and AMERISAFE, Inc. scores 96/100 among other insurers.

Piotroski F-Score Partial

4/6

AMERISAFE, Inc. passes 4 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 2 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Low Quality

0.24x

For every $1 of reported earnings, AMERISAFE, Inc. generates $0.24 in operating cash flow ($11.1M OCF vs $47.1M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$92.0M

YoY+13.4%

QoQ+14.8%

5Y CAGR+2.5%

10Y CAGR-0.6%

AMERISAFE, Inc. generated $92.0M in revenue in Q2 2026. This represents an increase of 13.4% from the same quarter a year earlier. Against the prior quarter it is up 14.8%.

Net Income

$14.6M

YoY+4.6%

QoQ+79.2%

5Y CAGR-9.3%

10Y CAGR-1.3%

AMERISAFE, Inc. reported $14.6M in net income in Q2 2026. This represents an increase of 4.6% from the same quarter a year earlier. Against the prior quarter it is up 79.2%.

EPS (Diluted)

$0.78

YoY+6.8%

QoQ+81.4%

5Y CAGR-8.7%

10Y CAGR-1.1%

AMERISAFE, Inc. earned $0.78 per diluted share (EPS) in Q2 2026. This represents an increase of 6.8% from the same quarter a year earlier. Against the prior quarter it is up 81.4%.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Free Cash Flow

$1.8M

YoY+118.8%

QoQ+165.7%

5Y CAGR-27.9%

10Y CAGR-23.3%

AMERISAFE, Inc. generated $1.8M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 118.8% from the same quarter a year earlier. Against the prior quarter it is up 165.7%.

Cash & Debt

$65.5M

YoY+35.1%

QoQ+91.3%

5Y CAGR+2.6%

10Y CAGR-0.7%

AMERISAFE, Inc. held $65.5M in cash as of Q2 2026; long-term debt is not reported for that period.

Dividends Per Share

$0.41

YoY+5.1%

QoQ0.0%

5Y CAGR+7.2%

10Y CAGR+8.6%

AMERISAFE, Inc. paid $0.41 per share in dividends in Q2 2026. This represents an increase of 5.1% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

19M

YoY-2.4%

QoQ-0.9%

5Y CAGR-0.9%

10Y CAGR-0.4%

AMERISAFE, Inc. had 19M shares outstanding in Q2 2026. This represents a decrease of 2.4% from the same quarter a year earlier. Against the prior quarter it is down 0.9%.

Margins & Returns

Net Margin

15.9%

YoY-1.3pp

QoQ+5.7pp

5Y change-13.4pp

10Y change-1.2pp

AMERISAFE, Inc.'s net profit margin was 15.9% in Q2 2026, showing the share of revenue converted to profit. This is down 1.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 5.7 percentage points.

Return on Equity

5.8%

YoY+0.6pp

QoQ+2.5pp

5Y change+0.8pp

10Y change+2.5pp

AMERISAFE, Inc.'s ROE was 5.8% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 0.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.5 percentage points.

Gross Margin

Not reported for Q2 2026.

Operating Margin

Not reported for Q2 2026.

Capital Allocation

Capital Expenditures

$3K

YoY-99.7%

QoQ-88.5%

5Y CAGR-56.8%

10Y CAGR-42.4%

AMERISAFE, Inc. invested $3K in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 99.7% from the same quarter a year earlier. Against the prior quarter it is down 88.5%.

R&D Spending

Not reported for Q2 2026.

Share Buybacks

Not reported for Q2 2026.

AMSF Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AMSF quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$335.6M	$317.3M+2.7%	$309.0M+0.7%	$306.9M+4.1%	$294.7M-6.7%	$315.9M-6.9%	$339.5M-8.3%	$370.4M-2.0%	$377.8M+0.7%	$375.2M-5.4%	$396.7M-1.1%	$401.0M-0.8%	$404.0M+13.4%	$356.3M+10.9%	$321.2M+14.5%	$280.7M
SG&A Expenses	$34.0M	$33.3M+5.6%	$31.5M+15.1%	$27.4M+3.2%	$26.5M+2.1%	$26.0M-7.1%	$27.9M+3.0%	$27.1M+4.3%	$26.0M+1.4%	$25.6M+3.0%	$24.9M+1.8%	$24.4M-0.3%	$24.5M+7.2%	$22.9M+9.7%	$20.8M+4.6%	$19.9M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$566K-56.8%	$1.3M
Income Tax	$11.6M	$11.7M-14.1%	$13.6M-10.8%	$15.3M+26.8%	$12.0M-12.0%	$13.7M-32.6%	$20.3M-11.0%	$22.8M+43.1%	$15.9M-55.7%	$36.0M+3.0%	$35.0M+14.6%	$30.5M+51.9%	$20.1M+29.0%	$15.6M+99.8%	$7.8M+145.3%	$3.2M
Net Income	$46.9M	$47.1M-15.0%	$55.4M-10.8%	$62.1M+11.7%	$55.6M-15.5%	$65.8M-24.0%	$86.6M-6.6%	$92.7M+29.4%	$71.6M+54.9%	$46.2M-40.6%	$77.9M+10.5%	$70.5M+31.3%	$53.7M+23.0%	$43.6M+48.7%	$29.4M+21.4%	$24.2M
EPS (Basic)	N/A	$2.48-14.8%	$2.91-10.2%	$3.24+12.1%	$2.89-15.0%	$3.40-24.3%	$4.49-6.8%	$4.82+29.2%	$3.73+54.8%	$2.41-40.9%	$4.08+9.7%	$3.72+29.2%	$2.88+21.5%	$2.37+46.3%	$1.62+22.7%	$1.32
EPS (Diluted)	$2.48	$2.47-14.5%	$2.89-10.5%	$3.23+12.2%	$2.88-15.0%	$3.39-24.2%	$4.47-6.9%	$4.80+29.4%	$3.71+54.6%	$2.40-40.7%	$4.05+9.8%	$3.69+29.9%	$2.84+22.4%	$2.32+46.8%	$1.58+22.5%	$1.29
Diluted Shares (Avg)	N/A	19M-0.4%	19M-0.3%	19M-0.5%	19M-0.4%	19M+0.2%	19M+0.2%	19M+0.2%	19M+0.2%	19M+0.2%	19M+0.4%	19M+1.0%	19M+1.0%	19M+0.9%	19M-0.6%	19M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$92.0M+13.4%	$80.1M+10.3%	$81.6M+10.2%	$82.0M+4.2%	$81.1M+6.9%	$72.6M-9.8%	$74.0M-7.6%	$78.7M+8.3%
SG&A Expenses	$8.5M+13.9%	$8.0M-3.6%	$9.2M+2.0%	$8.3M+7.5%	$7.5M+3.0%	$8.3M+10.4%	$9.0M+16.5%	$7.7M+12.2%
Income Tax	$3.7M+4.9%	$2.0M-11.3%	$2.3M-36.6%	$3.7M+5.6%	$3.5M+27.2%	$2.3M-40.5%	$3.6M-24.9%	$3.5M+46.6%
Net Income	$14.6M+4.6%	$8.1M-9.0%	$10.4M-21.1%	$13.8M-3.5%	$14.0M+26.9%	$8.9M-47.1%	$13.2M-31.4%	$14.3M+43.8%
EPS (Basic)	$0.79+8.2%	$0.43-8.5%	$0.55-21.4%	$0.73-2.7%	$0.73+25.9%	$0.47-47.2%	$0.70-30.0%	$0.75+44.2%
EPS (Diluted)	$0.78+6.8%	$0.43-8.5%	$0.55-19.1%	$0.72-4.0%	$0.73+28.1%	$0.47-46.6%	$0.68-32.0%	$0.75+44.2%
Diluted Shares (Avg)	19M-2.2%	19M-1.5%	N/A	19M-0.2%	19M-0.1%	19M-0.3%	N/A	19M-0.6%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA, Interest Expense.

AMSF Balance Sheet

AMSF quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$1.1B-2.4%	$1.2B-5.8%	$1.2B-3.2%	$1.3B-9.5%	$1.4B-4.6%	$1.5B-1.5%	$1.5B-1.5%	$1.5B-0.2%	$1.5B0.0%	$1.5B+1.1%	$1.5B+3.1%	$1.5B+9.6%	$1.3B+8.9%	$1.2B+6.7%	$1.1B
Cash & Equivalents	$61.9M+40.6%	$44.0M+13.9%	$38.7M-37.1%	$61.5M-13.1%	$70.7M+14.5%	$61.8M+41.0%	$43.8M+8.6%	$40.3M-27.4%	$55.6M-5.7%	$58.9M-15.2%	$69.5M-23.6%	$91.0M-26.1%	$123.1M+32.8%	$92.7M+103.5%	$45.5M
Short-Term Investments	$350.1M+3764276.3%	$9K	$0-100.0%	$491.7M-10.5%	$549.2M-6.1%	$585.1M	$0-100.0%	$14.2M-44.8%	$25.8M-12.9%	$29.6M+283.3%	$7.7M-77.1%	$33.7M-60.1%	$84.4M+22.5%	$68.9M+46.8%	$46.9M
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$878.9M-2.4%	$900.5M-3.9%	$936.7M-1.6%	$951.8M-5.1%	$1.0B-2.8%	$1.0B-2.9%	$1.1B-3.9%	$1.1B+1.2%	$1.1B+2.8%	$1.1B+1.4%	$1.0B+3.7%	$1.0B+10.8%	$912.2M+8.6%	$839.7M+5.7%	$794.5M
Total Equity	$251.6M-2.2%	$257.3M-12.0%	$292.5M-7.9%	$317.4M-20.5%	$399.3M-9.0%	$438.8M+2.0%	$430.2M+5.0%	$409.8M-3.7%	$425.4M-6.7%	$456.1M+0.5%	$454.0M+1.6%	$447.0M+7.2%	$416.8M+9.3%	$381.2M+9.1%	$349.4M
Retained Earnings	$82.8M-1.5%	$84.1M-26.4%	$114.3M-21.5%	$145.5M-23.6%	$190.5M-15.2%	$224.6M-1.1%	$227.2M+2.6%	$221.3M-5.4%	$233.9M-13.5%	$270.4M+0.6%	$268.9M+0.6%	$267.2M+6.6%	$250.7M+17.7%	$213.0M+16.0%	$183.7M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$1.1B-2.4%	$1.1B-2.9%	$1.1B-2.4%	$1.2B-7.2%	$1.2B-6.4%	$1.2B-7.0%	$1.2B-5.8%	$1.3B-3.2%
Cash & Equivalents	$65.5M+35.1%	$34.2M-23.5%	$61.9M+40.6%	$54.7M-14.0%	$48.5M+58.3%	$44.8M+34.1%	$44.0M+13.9%	$63.7M+7.4%
Short-Term Investments	$332.7M-13.5%	$340.5M-14.7%	$350.1M+3764276.3%	$372.0M-14.7%	$384.8M-17.2%	$399.2M-16.0%	$9K	$436.4M-10.4%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$877.3M-1.4%	$876.4M-2.2%	$878.9M-2.4%	$890.2M-5.3%	$889.5M-4.6%	$895.9M-4.9%	$900.5M-3.9%	$940.4M-2.1%
Total Equity	$250.0M-5.9%	$246.6M-5.5%	$251.6M-2.2%	$274.8M-12.6%	$265.6M-11.8%	$260.8M-13.4%	$257.3M-12.0%	$314.4M-6.4%
Retained Earnings	$90.3M-2.0%	$83.3M-2.7%	$82.8M-1.5%	$98.5M-27.2%	$92.1M-28.1%	$85.6M-31.0%	$84.1M-26.4%	$135.3M-19.9%

Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Goodwill, Current Liabilities, Non-Current Liabilities, Long-Term Debt.

AMSF Cash Flow Statement

AMSF quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$20.4M	$11.1M-54.2%	$24.2M-18.9%	$29.8M+5.8%	$28.2M-25.8%	$38.0M-40.1%	$63.4M-19.6%	$78.8M-19.8%	$98.3M-24.9%	$130.8M+14.5%	$114.2M+23.0%	$92.9M-34.0%	$140.7M+8.9%	$129.2M+59.4%	$81.0M+85.4%	$43.7M
Depreciation & Amortization	N/A	$1.2M-22.4%	$1.5M-14.7%	$1.7M+16.3%	$1.5M+37.4%	$1.1M+7.4%	$1.0M+1.4%	$1.0M+0.8%	$996K+1.2%	$984K-16.7%	$1.2M-12.4%	$1.3M+3.9%	$1.3M-0.2%	$1.3M	N/A	N/A
Stock-Based Compensation	N/A	$2.9M-1.1%	$2.9M+88.8%	$1.6M-37.2%	$2.5M+6.9%	$2.3M-29.6%	$3.3M+40.2%	$2.4M+13.8%	$2.1M+2.3%	$2.0M+25.9%	$1.6M+31.1%	$1.2M-19.5%	$1.5M+7.8%	$1.4M+119.8%	$641K+36.1%	$471K
Capital Expenditures	$1.1M	$2.1M+155.7%	$840K+51.9%	$553K-73.5%	$2.1M+61.2%	$1.3M+40.7%	$921K-9.5%	$1.0M-9.6%	$1.1M+135.6%	$478K-70.8%	$1.6M+71.9%	$953K-3.6%	$989K-13.2%	$1.1M-4.7%	$1.2M+6.0%	$1.1M
Free Cash Flow	$19.3M	$8.9M-61.8%	$23.4M-20.3%	$29.3M+12.2%	$26.1M-28.8%	$36.7M-41.3%	$62.5M-19.7%	$77.8M-19.9%	$97.1M-25.5%	$130.3M+15.8%	$112.6M+22.5%	$91.9M-34.2%	$139.7M+9.1%	$128.0M+60.3%	$79.9M+87.5%	$42.6M
Investing Cash Flow	$65.6M	$68.4M-5.5%	$72.4M+64.9%	$43.9M-41.8%	$75.4M+6.3%	$71.0M+63.6%	$43.4M+271.1%	$11.7M+140.2%	-$29.1M+43.6%	-$51.5M-2.1%	-$50.5M	N/A	N/A	N/A	-$9.3M+78.3%	-$42.9M
Financing Cash Flow	-$69.0M	-$61.6M+32.4%	-$91.2M+5.5%	-$96.5M+14.5%	-$112.9M-12.9%	-$100.0M-12.6%	-$88.8M-2.0%	-$87.0M-3.1%	-$84.4M-2.2%	-$82.6M-11.3%	-$74.3M	N/A	N/A	N/A	-$24.6M-51.8%	-$16.2M
Dividends Paid	$63.2M	$62.7M-11.7%	$71.0M+26.8%	$56.0M-27.9%	$77.7M-47.6%	$148.4M+67.5%	$88.6M-23.6%	$115.9M+77.2%	$65.4M-17.1%	$78.9M+17.8%	$67.0M+34.0%	$50.0M+100.0%	$25.0M+66.7%	$15.0M-28.6%	$21.0M-34.4%	$32.0M
Share Buybacks	N/A	N/A	N/A	$2.2M-82.5%	$12.4M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$10.3M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$1.8M+121.2%	-$2.7M-50.6%	$10.6M-1.9%	$10.7M+26.4%	-$8.4M-225.7%	-$1.8M-123.9%	$10.8M+172.9%	$8.4M+64.6%
Depreciation & Amortization	$178K-8.7%	$175K-18.2%	$150K-41.9%	$183K-33.9%	$195K-15.2%	$214K-34.8%	$258K-27.3%	$277K-25.7%
Stock-Based Compensation	$800K+14.3%	$586K-45.4%	N/A	$800K0.0%	$700K0.0%	$1.1M+56.0%	N/A	$800K+60.0%
Capital Expenditures	$3K-99.7%	$26K+1200.0%	$173K+1135.7%	$891K+3612.5%	$1.1M+1832.1%	$2K-99.7%	$14K-46.2%	$24K-95.1%
Free Cash Flow	$1.8M+118.8%	-$2.7M-51.8%	$10.4M-3.4%	$9.8M+16.2%	-$9.5M-259.7%	-$1.8M-126.5%	$10.8M+174.4%	$8.4M+81.5%
Investing Cash Flow	$42.7M+84.7%	-$12.5M-225.4%	$30.7M-8.9%	$4.6M-86.0%	$23.1M+101.3%	$9.9M+274.0%	$33.8M-34.2%	$32.8M+21.8%
Financing Cash Flow	-$13.3M-20.9%	-$12.5M-68.3%	-$34.2M+46.8%	-$9.0M-9.4%	-$11.0M+5.9%	-$7.4M-4.9%	-$64.2M+15.3%	-$8.2M-21.8%
Dividends Paid	$7.6M+1.9%	$7.8M+4.6%	$40.3M-19.0%	$7.5M+5.8%	$7.5M+5.4%	$7.4M+4.9%	$49.7M+37.0%	$7.1M+7.9%

Not reported in any period shown, so not listed: Share Buybacks.

AMSF Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AMSF quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Net Margin	14.8%-3.1pp	17.9%-2.3pp	20.2%+1.4pp	18.9%-2.0pp	20.8%-4.7pp	25.5%+0.5pp	25.0%+6.1pp	19.0%+6.6pp	12.3%-7.3pp	19.6%+2.1pp	17.6%+4.3pp	13.3%+1.0pp	12.3%+3.1pp	9.1%+0.5pp	8.6%
Return on Equity	18.7%-2.8pp	21.5%+0.3pp	21.2%+3.7pp	17.5%+1.0pp	16.5%-3.3pp	19.7%-1.8pp	21.6%+4.1pp	17.5%+6.6pp	10.9%-6.2pp	17.1%+1.5pp	15.5%+3.5pp	12.0%+1.5pp	10.5%+2.8pp	7.7%+0.8pp	6.9%
Return on Assets	4.2%-0.6pp	4.8%-0.3pp	5.1%+0.7pp	4.4%-0.3pp	4.7%-1.2pp	5.9%-0.3pp	6.2%+1.5pp	4.7%+1.7pp	3.0%-2.1pp	5.1%+0.4pp	4.7%+1.0pp	3.7%+0.4pp	3.3%+0.9pp	2.4%+0.3pp	2.1%
Debt-to-Equity	3.490.0x	3.50+0.3x	3.20+0.2x	3.00+0.5x	2.51+0.2x	2.35-0.1x	2.47-0.2x	2.70+0.1x	2.57+0.2x	2.330.0x	2.310.0x	2.26+0.1x	2.190.0x	2.20-0.1x	2.27
Asset Turnover	0.280.0x	0.270.0x	0.250.0x	0.230.0x	0.230.0x	0.230.0x	0.250.0x	0.250.0x	0.250.0x	0.260.0x	0.270.0x	0.280.0x	0.270.0x	0.260.0x	0.25
FCF Margin	2.8%-4.8pp	7.6%-2.0pp	9.5%+0.7pp	8.9%-2.7pp	11.6%-6.8pp	18.4%-2.6pp	21.0%-4.7pp	25.7%-9.0pp	34.7%+6.4pp	28.4%+5.5pp	22.9%-11.7pp	34.6%-1.4pp	35.9%+11.1pp	24.9%+9.7pp	15.2%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Net Margin	15.9%-1.3pp	10.2%-2.2pp	12.7%-5.0pp	16.9%-1.3pp	17.2%+2.7pp	12.3%-8.7pp	17.8%-6.2pp	18.2%+4.5pp
Return on Equity	5.8%+0.6pp	3.3%-0.1pp	4.1%-1.0pp	5.0%+0.5pp	5.3%+1.6pp	3.4%-2.2pp	5.1%-1.5pp	4.6%+1.6pp
Return on Assets	1.3%+0.1pp	0.7%0.0pp	0.9%-0.2pp	1.2%+0.1pp	1.2%+0.3pp	0.8%-0.6pp	1.1%-0.4pp	1.1%+0.4pp
Debt-to-Equity	3.51+0.2x	3.55+0.1x	3.490.0x	3.24+0.2x	3.35+0.3x	3.44+0.3x	3.50+0.3x	2.99+0.1x
Asset Turnover	0.080.0x	0.070.0x	0.070.0x	0.070.0x	0.070.0x	0.060.0x	0.060.0x	0.060.0x
FCF Margin	1.9%+13.7pp	-3.4%-0.9pp	12.8%-1.8pp	11.9%+1.2pp	-11.8%-8.3pp	-2.5%-10.9pp	14.6%+9.7pp	10.7%+4.3pp

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
AMERISAFE, Inc. AMSF	FY2025	$317.3M	$47.1M	14.8%	$452.5M	53/100
Tiptree Inc. TIPT	FY2025	$488K	$34.9M	N/A	$642.4M	—
Employers Holdings, Inc. EIG	FY2025	$858.7M	$10.8M	1.3%	$887.2M	40/100
Investors Title Co ITIC	FY2025	$272.8M	$35.2M	12.9%	$560.6M	38/100
Ambac Financial Group, Inc. AMBC	FY2025	$251.2M	-$259.0M	N/A	$395.6M	21/100
MBIA Inc. MBI	FY2025	$80.0M	-$177.0M	N/A	$230.6M	2/100

Where AMERISAFE, Inc. Ranks

Frequently Asked Questions

What is AMERISAFE, Inc.'s annual revenue?

AMERISAFE, Inc. (AMSF) reported $317.3M in total revenue for fiscal year 2025. This represents a 2.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is AMERISAFE, Inc.'s revenue growing?

AMERISAFE, Inc. (AMSF) revenue grew by 2.7% year-over-year, from $309.0M to $317.3M in fiscal year 2025.

Is AMERISAFE, Inc. profitable?

Yes, AMERISAFE, Inc. (AMSF) reported a net income of $47.1M in fiscal year 2025, with a net profit margin of 14.8%.

What is AMERISAFE, Inc.'s net profit margin?

AMERISAFE, Inc. (AMSF) had a net profit margin of 14.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does AMERISAFE, Inc. pay dividends?

Yes, AMERISAFE, Inc. (AMSF) paid $1.56 per share in dividends during fiscal year 2025.

What is AMERISAFE, Inc.'s return on equity (ROE)?

AMERISAFE, Inc. (AMSF) has a return on equity of 18.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is AMERISAFE, Inc.'s free cash flow?

AMERISAFE, Inc. (AMSF) generated $8.9M in free cash flow during fiscal year 2025. This represents a -61.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is AMERISAFE, Inc.'s operating cash flow?

AMERISAFE, Inc. (AMSF) generated $11.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are AMERISAFE, Inc.'s total assets?

AMERISAFE, Inc. (AMSF) had $1.1B in total assets as of fiscal year 2025, including both current and long-term assets.

What are AMERISAFE, Inc.'s capital expenditures?

AMERISAFE, Inc. (AMSF) invested $2.1M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How many shares does AMERISAFE, Inc. have outstanding?

AMERISAFE, Inc. (AMSF) had 19M shares outstanding as of fiscal year 2025.

What is AMERISAFE, Inc.'s debt-to-equity ratio?

AMERISAFE, Inc. (AMSF) had a debt-to-equity ratio of 3.49 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is AMERISAFE, Inc.'s return on assets (ROA)?

AMERISAFE, Inc. (AMSF) had a return on assets of 4.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is AMERISAFE, Inc.'s P/E ratio?

AMERISAFE, Inc. (AMSF) trades at 9.6x earnings, its market capitalization divided by net income of $46.9M net income, trailing 12 months to June 30, 2026. The market capitalization is $452.5M as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is AMERISAFE, Inc.'s price-to-sales ratio?

AMERISAFE, Inc. (AMSF) trades at 1.3x sales, its market capitalization divided by revenue of $335.6M revenue, trailing 12 months to June 30, 2026. The market capitalization is $452.5M as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is AMERISAFE, Inc.'s Piotroski F-Score?

AMERISAFE, Inc. (AMSF) has a Piotroski F-Score of 4 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are AMERISAFE, Inc.'s earnings high quality?

AMERISAFE, Inc. (AMSF) has an earnings quality ratio of 0.24x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is AMERISAFE, Inc.?

AMERISAFE, Inc. (AMSF) scores 53 out of 100 on our Financial Health Score, indicating moderate standing within its insurers peer group. The score is a 0-100 composite of six dimensions (Loss Ratio, Premium Growth, Capital, Investment Yield, Combined Ratio, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.